Endocare Management Team
5 Team Members
Endocare has 5 executives. Endocare's current Chief Executive Officer, President is Paul Mikus.
Compare Endocare to Competitors
REPROCELL is a company focused on supporting stem cell research and preclinical drug development within the biotechnology sector. The company offers a range of services including stem cell research, drug discovery, analytical services, gene editing, precision medicine, and clinical laboratory services, as well as products such as stem cell reagents, cells, and 3D cell culture systems. REPROCELL's clientele primarily consists of research institutions and companies in the regenerative medicine and pharmaceutical industries. It was founded in 2003 and is based in Yokohama, Japan.
Stemina Biomarker Discovery is a developer of molecular biomarkers designed to perform diagnosis and treat neurological disorders, including autism spectrum disorders. It offers the discovery, development, and commercialization of molecular biomarkers for drug safety and human health. It provides compound screening and diagnostic development for the pharmaceutical and biotechnology industries. The company was founded in 2006 and is based in Madison, Wisconsin.
CoImmune is a company that focuses on the development and manufacture of cell-based therapeutics, operating within the healthcare and biotechnology sectors. The company's main offerings include treatments for unmet medical needs such as cancer, autoimmune, and inflammatory diseases. It was founded in 1997 and is based in Durham, North Carolina. CoImmune operates as a subsidiary of Genexine and SCM Lifescience.
Esperance Pharmaceuticals develops targeted anticancer drugs that selectively kill cancer cells without harming normal cells.
Humanetics is a clinical-stage pharmaceutical company engaged in developing and commercializing products to enhance human health and well-being in markets with urgent and unmet needs. It has a focus on radiation modulators for oncology, medical imaging, and medical countermeasure uses. The company develops BIO 300, a selective modulator of inflammation, cell cycle arrest, and DNA damage repair. Humanetics was founded in 1988 and is based in Minneapolis, Minnesota.
Keystone Nano seeks to improve human health by creating new ways to diagnose and treat human diseases and improve the quality of life. Keystone Nano partners with healthcare companies to the development and speed the market launch of nano-enabled therapeutics to seek/treat/image a variety of conditions.